|
Medicines Research: current
trends and case histories.
9th December 2008 |
|
| Programme: | |
| 09.00 | Registration opens |
| BioLondon Cafe & Exhibition Opens | |
| 09.30 | Welcome - Baroness Jo Valentine, Chief Executive, London First |
| 09.40 | PLENARY SESSION: Opening Address - Professor Dame Julia Polak |
| 10.00 |
Chris Brinsmead, President AstraZeneca
UK / President ABPI (invited) 'I have a dream!’ |
| 10.20 |
Dennis Smith, Pfizer UK Pharma, a victim of its own success? |
| 10.40 |
Baroness Susan Greenfield Healthy people on a healthy planet: Is biotechnology the answer? |
| 11.00 | Coffee/Tea, networking and exhibitor visits |
| SMR break out stream: Medicines Research: current trends and case histories Trends: | |
| 11.30 |
Ming Zhang, Biotica Optimizing nature’s privileged structures in nature’s way? |
| 12.00 |
Douglas Williamson, Vernalis |
| 12.30 | SMR AGM & Exhibition |
| 13.00 | Lunch |
| Case Histories: | |
| 14.00 |
Sam Butterworth, AstraZeneca The discovery of AZD1152: a selective inhibitor of Aurora B kinase with potent anti-tumour activity. |
| 14.30 |
Michael Roe, Vantia Discovery of agonists and antagonists of the vasopressin receptors |
| 15.00 |
Thien Duc Tran, Pfizer Design and synthesis of gp120-CD4 inhibitors for the treatment of HIV |
| 15.30 | Tea |
| 16.15 |
Emmanuel Demont, GSK The discovery of orally active BACE-1 Inhibitors |
| 16.45 |
Dennis Smith, Pfizer Is a historical perspective useful in predicting the future of drug discovery and development? |
| 17.30 | Close of SMR Meeting |
| 17.45 | Drinks Reception |
| 19.00 | Close |
| Home / Meetings / Membership / Student Bursaries / Administration / History of the SMR / SMR Award / Archive Material / Links / Contact Us |